CopyMark Law Group
4.9/5
Drawing for GALLIMBERTI BONCI

USPTO serial 79272750

GALLIMBERTI BONCI

Reviewed by CopyMark Law Group

Reg. 6331020Status 700Renewal
Filing date
Status date
Registration date
Apr 27, 2021
Examiner
CROWDER-SCHAEFER, ANDREW W
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with GALLIMBERTI BONCI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*

Plus Government fees of $650

Trademark Monitoring(312) 319-4460
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Start a new application
(312) 319-4460

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Alexander Butterman

Alexander Butterman Dunlap Bennett and Ludwig PLLC211 Church St., SELeesburg, VA 20175UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Scientific research for medical purposes; clinical research in the fields of brain stimulation and cocaine addiction; medical and pharmacological research services; conducting clinical trials in the fields of brain stimulation and cocaine addiction; biological research, clinical research and medical research in the fields of brain stimulation and cocaine addiction; medical research services; scientific research and development; scientific technological services, namely, scientific research and development in the fields of brain stimulation and cocaine addictionACTIVE—
044Withdrawal treatments services for addicts; rehabilitation of narcotic addicted patients, rehabilitation of drug addicted patients; health clinic services featuring addiction treatment services; human healthcare services; medical clinic services; laboratory analysis services relating to the treatment of persons, namely, detecting and assessing drug addictions; brain stimulation therapy servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 27, 2026REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 4, 2021FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 11, 2021XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Aug 11, 2021XXCRGENERIC MADRID TRANSACTION CREATED—
Jul 27, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 27, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 9, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 9, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 6, 2021GPNXNOTIFICATION PROCESSED BY IB—
Jan 20, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jan 20, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jan 20, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 4, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 4, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Jan 4, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 4, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 4, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Dec 15, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 15, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 15, 2020ALIEASSIGNED TO LIE—
Sep 22, 2020NREVNOTICE OF REVIVAL - E-MAILED—
Sep 21, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 21, 2020PETGPETITION TO REVIVE-GRANTED—
Sep 21, 2020PROATEAS PETITION TO REVIVE RECEIVED—
Jul 20, 2020MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 20, 2020ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jan 24, 2020RFNTREFUSAL PROCESSED BY IB—
Jan 6, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 6, 2020RFRRREFUSAL PROCESSED BY MPU—
Dec 6, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Dec 5, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 3, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 29, 2019DOCKASSIGNED TO EXAMINER—
Nov 29, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 28, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance